0 التعليقات
0 المشاركات
119 مشاهدة
0 معاينة
البحث
إكتشاف أشخاص جدد وإنشاء اتصالات جديدة وصداقات جديدة
-
الرجاء تسجيل الدخول , للأعجاب والمشاركة والتعليق على هذا!
-
Breakthrough Treatments Reshaping the Glioblastoma Multiforme MarketGlioblastoma multiforme (GBM) is the most aggressive form of brain cancer, with a poor prognosis and limited treatment options. The current glioblastoma multiforme survival rate remains dismal, with the majority of patients surviving only 12 to 18 months post-diagnosis. However, promising advancements in treatment, including the IMVAX clinical trial, are paving the way for...0 التعليقات 0 المشاركات 1كيلو بايت مشاهدة 0 معاينة
-
Rising Glioblastoma Cases and Unmet Needs Pushing Market ExpansionGlioblastoma Multiforme (GBM) is the most aggressive and lethal form of brain cancer, with a poor prognosis and limited treatment options. Despite advancements in cancer research, the survival rate for GBM patients remains low, highlighting the urgent need for more effective therapies. The current standard of care includes surgery, radiation, and chemotherapy, but these treatments...0 التعليقات 0 المشاركات 1كيلو بايت مشاهدة 0 معاينة